We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. On December 15, 2025, UBS reaffirmed its Neutral (Hold) rating on NVO with an unchanged price target of DKK 295, ...
So far five companies have agreed to the terms. They are Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk and EMD Serono, which ...
The White House is set to announce drug pricing deals with pharmaceutical giants Novartis and Roche Holding as soon as Friday ...
By Mike Dolan Dec 16 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets The ...
A federal judicial panel ordered that lawsuits alleging vision loss from Novo Nordisk’s (NVO) and Eli Lilly’s (LLY) weight-loss drugs be ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's blood ...
Health and Me on MSN
Ozempic launches in India at Rs 2,200 for starter dose: All you need to know
Novo Nordisk has launched its popular diabetes drug Ozempic in India, with the weekly 0.25 mg starter dose priced at ₹2,200.
Novo Nordisk has officially launched Ozempic for diabetes treatment in India. Let's learn more about how this injection works ...
Investor's Business Daily on MSN
Eli Lilly Rises, Again, After EMA Groups Recommends Mounjaro For Children As Young As 10
On Friday, an EMA committee recommended extending the use of Eli Lilly's type 2 diabetes drug, Mounjaro, to children as young ...
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback